RVT Stock Analysis: Royce Value | NYSE

Asset Management | NYSE, USA | Market Cap: 2.260m USD | 12M Return: 29.1% | Charts, Fundamentals & Technical Analysis

Small-Cap Equities, Micro-Cap Equities, Value Investing, Mutual Fund
Total Rating 46
Safety 34
Buy Signal -0.52
Asset Management
Industry Rotation: +0.7
Market Cap: 2.26B
Avg Turnover: 7.62M
Risk 3d forecast
Volatility18.5%
VaR 5th Pctl3.30%
VaR vs Median8.06%
Reward TTM
Sharpe Ratio1.27
Rel. Str. IBD60.9
Rel. Str. Peer Group71.4
Character TTM
Beta1.089
Beta Downside1.120
Hurst Exponent0.551
Drawdowns 3y
Max DD23.48%
CAGR/Max DD0.80
CAGR/Mean DD4.32

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 10.5 years of data

Jan +0.2% 5
Feb +0.3% 0
Mar -1.9% 57
Apr +0.8% 0
May -0.4% 0
Jun -0.6% 2
Jul +0.8% 13
Aug -1.1% 20
Sep -1.5% 9
Oct -2.3% 35
Nov +1.4% 31
Dec +0.0% 8

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: RVT Royce Value

Royce Small-Cap Trust, Inc. (NYSE: RVT) is a U.S.-domiciled, close-ended equity mutual fund launched and managed by Royce & Associates, LLC. Formed on July 1, 1986 and listed on the exchange on December 30, 1987, the fund invests in value-oriented stocks of small-cap and micro-cap companies across diversified sectors of the U.S. public equity markets. It measures its performance against the Russell 2000 Index and is classified within the Financials sector under the GICS Asset Management & Custody Banks sub-industry, with a market capitalization of approximately $2.2 billion.

As a closed-end fund, RVT issues a fixed number of shares that trade on an exchange, allowing its market price to fluctuate independently of the funds net asset value-often at a premium or discount, which is a key characteristic investors monitor. The manager, Royce & Associates, has historically specialized in small-cap value investing, a strategy that emphasizes companies with low relative valuations within the smaller end of the U.S. equity market.

Headlines to Watch Out For
  • Small-cap value rotation narrows RVT discount to NAV
  • Russell 2000 performance drives NAV higher
  • Fed rate cuts pressure small-cap valuations and distributions
Piotroski VR-10 (Strict) 5.0
Net Income: 262.2m TTM > 0 and > 6% of Revenue
FCF/TA: 0.02 > 0.02 and ΔFCF/TA 2.04 > 1.0
NWC/Revenue: -24.52% < 20% (prev -3.07%; Δ -21.46% < -1%)
CFO/TA 0.00 > 3% & CFO 5.44m > Net Income 262.2m
Net Debt (34.9m) to EBITDA (221.1m): 0.16 < 3
Current Ratio: 0.08 > 1.5 & < 3
Outstanding Shares: last quarter (120.4m) vs 12m ago 6.20% < -2%
Gross Margin: 86.21% > 18% (prev 7.36%; Δ 78.85% > 0.5%)
Asset Turnover: 6.98% > 50% (prev 1.16%; Δ 5.82% > 0%)
Interest Coverage Ratio: 243.3 > 6 (EBIT TTM 221.1m / Interest Expense TTM 909k)
Altman Z'' 10.00
A: -0.02 (Total Current Assets 3.15m - Total Current Liabilities 39.1m) / Total Assets 2.17b
B: 0.29 (Retained Earnings 620.2m / Total Assets 2.17b)
C: 0.11 (EBIT TTM 221.1m / Avg Total Assets 2.10b)
D: 480.8 (Book Value of Equity 2.16b / Total Liabilities 4.50m)
Altman-Z'' = 506.3 = AAA
What is the price of RVT shares?

As of July 08, 2026, the stock is trading at USD 18.17 with a total of 409,330 shares traded. Over the past week, the price has changed by -1.03%, over one month by +4.10%, over three months by +9.71% and over the past year by +29.14%.

Current recommended Stop Loss: 17.30 (which is 4.8% or 2.5 ATR below the current price).

Is RVT a buy, sell or hold?

Royce Value has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy RVT.

  • StrongBuy: 1
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

Royce Value (RVT) - Fundamental Data Overview as of 05 July 2026
Market Cap USD = 2.26b (2.26b USD * 1.0 USD.USD)
P/E Trailing = 6.369
P/S = 82.9315
P/B = 1.0442
Revenue TTM = 146.7m USD
EBIT TTM = 221.1m USD
EBITDA TTM = 221.1m USD
 Long Term Debt = unknown (none)
 Short Term Debt = 35.0m USD (from shortTermDebt, two quarters ago)
Debt = 35.0m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 34.9m USD (calculated: Debt 35.0m - CCE 116k)
Enterprise Value = 2.29b USD (2.26b + Debt 35.0m - CCE 116k)
Interest Coverage Ratio = 243.3 (Ebit TTM 221.1m / Interest Expense TTM 909k)
EV/FCF = 53.54x (Enterprise Value 2.29b / FCF TTM 42.9m)
FCF Yield = 1.87% (FCF TTM 42.9m / Enterprise Value 2.29b)
FCF Margin = 29.22% (FCF TTM 42.9m / Revenue TTM 146.7m)
Net Margin = 178.7% (Net Income TTM 262.2m / Revenue TTM 146.7m)
Gross Margin = 86.21% ((Revenue TTM 146.7m - Cost of Revenue TTM 20.2m) / Revenue TTM)
Gross Margin QoQ = 92.36% (prev 28.42%)
Tobins Q-Ratio = 1.06 (Enterprise Value 2.29b / Total Assets 2.17b)
Interest Expense / Debt = 2.60% (Interest Expense 909k / Debt 35.0m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 174.6m (EBIT 221.1m * (1 - 21.00%))
Current Ratio = 0.08 (Total Current Assets 3.15m / Total Current Liabilities 39.1m)
Debt / Equity = 0.02 (Debt 35.0m / totalStockholderEquity, last quarter 2.16b)
Debt / EBITDA = 0.16 (Net Debt 34.9m / EBITDA 221.1m)
Debt / FCF = 0.81 (Net Debt 34.9m / FCF TTM 42.9m)
Total Stockholder Equity = 2.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.47% (Net Income 262.2m / Total Assets 2.17b)
RoE = 12.99% (Net Income TTM 262.2m / Total Stockholder Equity 2.02b)
RoCE = 10.38% (EBIT 221.1m / Capital Employed (Total Assets 2.17b - Current Liab 39.1m))
RoIC = 8.07% (NOPAT 174.6m / Invested Capital 2.16b)
WACC = 9.69% (E(2.26b)/V(2.30b) * Re(9.81%) + D(35.0m)/V(2.30b) * Rd(2.60%) * (1-Tc(0.21)))
Discount Rate = 9.81% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 95.56 | Cagr: 7.63%
[DCF] Terminal Value 70.87% ; FCFF base≈42.9m ; Y1≈43.0m ; Y5≈45.6m
[DCF] Fair Price = 4.43 (EV 577.4m - Net Debt 34.9m = Equity 542.5m / Shares 122.4m; r=9.69% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.13 | # QB: 0
Revenue Correlation: 16.99 | Revenue CAGR: 21.50% | SUE: N/A | # QB: 0